Capital Advisors Ltd’s Biogen BIIB Stock Holding History

Capital Advisors Ltd’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50K	Hold	232	–	–	0.01%	507
2026 Q1	$43K	Hold	232	–	–	﹤0.01%	527
2025 Q4	$41K	Hold	232	–	–	﹤0.01%	525
2025 Q3	$32K	Buy	232 +52	+29%	+$7.03K	﹤0.01%	561
2025 Q2	$23K	Sell	180 -68	-27%	-$8.47K	﹤0.01%	601
2025 Q1	$34K	Buy	248 +38	+18%	+$5.43K	﹤0.01%	524
2024 Q4	$32K	Buy	210 +43	+26%	+$7.25K	﹤0.01%	529
2024 Q3	$32K	Sell	167 -21	-11%	-$4.39K	﹤0.01%	530
2024 Q2	$44K	Buy	188 +15	+9%	+$3.26K	0.01%	465
2024 Q1	$37K	Hold	173	–	–	﹤0.01%	484
2023 Q4	$45K	Hold	173	–	–	0.01%	439
2023 Q3	$44K	Sell	173 -8	-4%	-$2.14K	0.01%	435
2023 Q2	$52K	Buy	181 +164	+965%	+$48.8K	0.01%	416
2023 Q1	$5K	Sell	17 -158	-90%	-$43.7K	﹤0.01%	664
2022 Q4	$3K	Buy	175 +166	+1,844%	+$46.9K	﹤0.01%	749
2022 Q3	$2K	Buy	+9	New	+$1.91K	﹤0.01%	809
2022 Q2	–	Sell	-17	Closed	-$4K	–	1010
2022 Q1	$4K	Sell	17 -3	-15%	-$652	﹤0.01%	592
2021 Q4	$5K	Buy	20 +3	+18%	+$771	﹤0.01%	564
2021 Q3	$5K	Hold	17	–	–	﹤0.01%	466
2021 Q2	$6K	Hold	17	–	–	﹤0.01%	439
2021 Q1	$5K	Hold	17	–	–	﹤0.01%	447
2020 Q4	$4K	Hold	17	–	–	﹤0.01%	426
2020 Q3	$5K	Hold	17	–	–	﹤0.01%	410
2020 Q2	$5K	Hold	17	–	–	﹤0.01%	404
2020 Q1	$5K	Hold	17	–	–	﹤0.01%	404
2019 Q4	$5K	Hold	17	–	–	﹤0.01%	379
2019 Q3	$4K	Hold	17	–	–	﹤0.01%	382
2019 Q2	$4K	Hold	17	–	–	﹤0.01%	410
2019 Q1	$4K	Hold	17	–	–	﹤0.01%	406
2018 Q4	$5K	Hold	17	–	–	﹤0.01%	402
2018 Q3	$6K	Hold	17	–	–	﹤0.01%	437
2018 Q2	$5K	Hold	17	–	–	﹤0.01%	367
2018 Q1	$5K	Hold	17	–	–	﹤0.01%	357
2017 Q4	$5K	Hold	17	–	–	﹤0.01%	363
2017 Q3	$5K	Hold	17	–	–	﹤0.01%	362
2017 Q2	$5K	Hold	17	–	–	﹤0.01%	363
2017 Q1	$5K	Hold	17	–	–	﹤0.01%	344
2016 Q4	$5K	Hold	17	–	–	﹤0.01%	334
2016 Q3	$5K	Hold	17	–	–	﹤0.01%	324
2016 Q2	$4K	Hold	17	–	–	﹤0.01%	314
2016 Q1	$4K	Hold	17	–	–	﹤0.01%	306
2015 Q4	$5K	Hold	17	–	–	﹤0.01%	291
2015 Q3	$5K	Hold	17	–	–	﹤0.01%	287
2015 Q2	$7K	Hold	17	–	–	﹤0.01%	296
2015 Q1	$7K	Hold	17	–	–	﹤0.01%	282
2014 Q4	$6K	Hold	17	–	–	﹤0.01%	278
2014 Q3	$5K	Hold	17	–	–	﹤0.01%	284
2014 Q2	$5K	Buy	+17	New	+$5.12K	﹤0.01%	292

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Advisors Ltd's BIIB Position: Q2 2026 in Review

Capital Advisors Ltd held its Biogen (BIIB) position steady in Q2 2026 at 232 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #507.

Capital Advisors Ltd first reported a position in BIIB in Q2 2014 and has held it in 48 quarters since. The position peaked at $52K in Q2 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Capital Advisors Ltd held 232 shares of Biogen worth $50K as of Q2 2026.
Capital Advisors Ltd left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #507 holding.
Capital Advisors Ltd first reported a position in Biogen in Q2 2014 and has held it in 48 quarters since.
Capital Advisors Ltd's Biogen position peaked at $52K in Q2 2023.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.